Annual Report

Overview

The report highlights BioArctic's continued progress in 2020 on the confirmatory Phase 3 study with lecanemab and the launch of an additional Phase 3 program for preclinical Alzheimer's disease. It also presents an updated sustainability strategy based on the UN Sustainable Development Goals, organized around sustainable employeeship, resource use and sustainable business. At year-end, the company had 45 employees, with 82 percent working in research and development.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2020
Period: Ends 31 December 2020
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Level
Standard
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services